<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://dspace.bsuedu.ru/handle/123456789/46279">
    <title>DSpace Community:</title>
    <link>http://dspace.bsuedu.ru/handle/123456789/46279</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://dspace.bsuedu.ru/handle/123456789/46665" />
        <rdf:li rdf:resource="http://dspace.bsuedu.ru/handle/123456789/46664" />
        <rdf:li rdf:resource="http://dspace.bsuedu.ru/handle/123456789/46663" />
        <rdf:li rdf:resource="http://dspace.bsuedu.ru/handle/123456789/46662" />
      </rdf:Seq>
    </items>
    <dc:date>2026-04-05T21:20:27Z</dc:date>
  </channel>
  <item rdf:about="http://dspace.bsuedu.ru/handle/123456789/46665">
    <title>Study of analgesic activity and effects of new dipharmacophores - nebracetam and cyclooxygenase-2 inhibitors derivatives on the cognitive abilities of rats</title>
    <link>http://dspace.bsuedu.ru/handle/123456789/46665</link>
    <description>Title: Study of analgesic activity and effects of new dipharmacophores - nebracetam and cyclooxygenase-2 inhibitors derivatives on the cognitive abilities of rats
Authors: Slyusarenko, V. S.; Kovalenko, S. M.; Chuev, V. P.; Gureev, V. V.; Korokin, M. V.
Abstract: The aim of the present study was to research the analgesic activity and effect of new dipharmacophore compounds consisting of substances with proven therapeutic activity, namely nebracetam-ibuprofen (NRIP), nebracetam-dexibuprofen (NRDIP), nebracetam-niflumic acid (NRNFA), and nebracetam-mefenamic acid (NRMFA), on the cognitive abilities of rats</description>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://dspace.bsuedu.ru/handle/123456789/46664">
    <title>Optimization of premedication of patients with arterial hypertension and severe ventricular rhythm disturbances with Amiodarone-associated thyrotoxicosis</title>
    <link>http://dspace.bsuedu.ru/handle/123456789/46664</link>
    <description>Title: Optimization of premedication of patients with arterial hypertension and severe ventricular rhythm disturbances with Amiodarone-associated thyrotoxicosis
Authors: Safronenko, A. V.; Lepyavka, S. V.; Demidov, I. A.; Nazheva, M. I.; Maklyakov, Y. S.
Abstract: The effectiveness of premedication of patients with arterial hypertension and severe ventricular rhythm disturbances against the background of Amiodarone-associated thyrotoxicosis, high anxiety and cyclothymiae disorders should be based on the pharmacological positions of the need to reduce the risk of dangerous adverse cardiovascular reactions</description>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://dspace.bsuedu.ru/handle/123456789/46663">
    <title>"The obesity paradox" in patients with atrial fibrillation according to the results of the REKUR-AF study</title>
    <link>http://dspace.bsuedu.ru/handle/123456789/46663</link>
    <description>Title: "The obesity paradox" in patients with atrial fibrillation according to the results of the REKUR-AF study
Authors: Polshakova, I. L.; Povetkin, S. V.; Gaponov, A. Y.
Abstract: To evaluate the effect of excess body weight (EBW) and obesity on the survival of patients with atrial fibrillation (AF) in the REKUR-AF study</description>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://dspace.bsuedu.ru/handle/123456789/46662">
    <title>Modern approaches to pharmacotherapy of tuberculosis infection in children</title>
    <link>http://dspace.bsuedu.ru/handle/123456789/46662</link>
    <description>Title: Modern approaches to pharmacotherapy of tuberculosis infection in children
Authors: Novikov, V. E.; Usacheva, N. E.; Myakisheva, T. V.
Abstract: Anti-tuberculosis drugs (anti-TB drugs) are divided into 3 lines, taking into account drug sensitivity in Mycobacterium tuberculosis (MBT). First-line anti-TB drugs (basic) are used to treat TB caused by drug-susceptible MBT. Second- and third-line (reserve) drugs are recommended for the treatment of MBT-induced multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB, respectively</description>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

